Leon Ravin
Psychiatry · Pittsburgh, PANPI 1760417364
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $82,350 of the $106,477 with a category attached, or 77.3%. 16 manufacturers reported payments, led by Alkermes, Inc. at 41.2% of the total. Reporting peaked in 2019 at $43,395 and has fallen 95.9% since, to $1,772 in 2025. Among psychiatry clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 475 payments — averaging $224.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$44K
- Johnson & Johnson$36K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$10K
- Bioxcel Therapeutics, Inc.$6K
- Otsuka America Pharmaceutical, Inc.$4K
- Neurocrine Biosciences, Inc.$2K
- plus $4K from 10 others
What the payments were for
- Speaking & faculty fees$82,35077%
- Travel & lodging$10,19310%
- Food & beverage$13,77913%
- Education$1560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 96 | $43,858 |
| Johnson & Johnson | 100 | $35,979 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 16 | $10,204 |
| Bioxcel Therapeutics, Inc. | 18 | $6,066 |
| Otsuka America Pharmaceutical, Inc. | 64 | $3,766 |
| Neurocrine Biosciences, Inc. | 60 | $2,250 |
| Teva Pharmaceuticals USA, Inc. | 18 | $1,150 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $894 |
| Sunovion Pharmaceuticals Inc. | 27 | $742 |
| Janssen Scientific Affairs, LLC | 4 | $342 |
| E.r. Squibb & Sons, L.L.C. | 4 | $307 |
| Indivior Inc. | 15 | $274 |
| AbbVie | 11 | $251 |
| Tris Pharma Inc | 2 | $220 |
| Vanda Pharmaceuticals Inc. | 7 | $157 |
| Lundbeck LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$167,963
- ARISTADA INITIO$41,875
- SPRAVATO$33,600
- IGALMI$5,655
- LYBALVI$1,208
- INGREZZA$905
- UZEDY$655
- INVEGA SUSTENNA$422
- LATUDA$364
- ABILIFY MAINTENA$250
- Onyda XR$220
- CAPLYTA$141
- COBENFY$117
How this compares
$106,477 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Other psychiatry in Pittsburgh
- Rebecca RomaPittsburgh$3.3M
- Mayer AyyashPittsburgh$714K
- Barbara NightingalePittsburgh$93K
- Mark FullerPittsburgh$38K
- Jasbir KangPittsburgh$16K
- Robert NelsonWyomissing$2.2M
- Matthew BergerMoosic$1.7M
- Mark MattaNew Castle$847K
- Daniel WeintraubPhiladelphia$647K
- Sachin MehtaBlue Bell$646K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.